Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for Opiate-Induced Constipation in ICU
NCT01050595Phase 3Unknown
- Sponsor
- Ascension St. John
- Start
- Dec 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylnaltrexone in opioid-induced constipation (OIC), sponsored by Ascension St. John. Status: unknown.
02
Drugs
methylnaltrexone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT01050595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01050595.